We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

4264:TADAWULFlynas Co. Analysis

Data as of 2026-05-21 - not real-time

¥1,690.00

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Secure, Inc. is trading just above its 20‑day simple moving average, with the 50‑day average still higher, indicating a modest upside bias. The RSI sits near the midpoint of its range, suggesting neutral momentum, while the MACD histogram has turned positive, providing a bullish technical signal. Volume has been trending upward, reinforcing the technical optimism, and the price remains comfortably above the identified support level while still below the next resistance barrier.
Fundamentally, the company is delivering strong top‑line growth of over 30% year‑over‑year, but its trailing P/E is well above the industry average, signaling current overvaluation. The forward P/E, however, drops dramatically, reflecting expectations of accelerating earnings. The balance sheet shows ample cash relative to debt, though the firm does not pay a dividend. Exposure is concentrated in Japan’s security and AI‑driven solutions market, positioning it for long‑term secular growth despite the present premium valuation.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 7/10

Key Factors

  • Bullish MACD histogram indicating short‑term upward momentum
  • Increasing trading volume supporting price stability
  • Price positioned above near‑term support with neutral RSI

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Robust revenue growth exceeding 30% YoY
  • Forward P/E suggesting significant earnings upside
  • Strong cash position relative to debt

Long Term

> 3 years
Neutral
Model confidence: 7/10

Key Factors

  • Long‑term secular demand for AI‑enabled security solutions
  • High current valuation limiting near‑term upside
  • Absence of dividend requiring reliance on capital appreciation

Key Metrics & Analysis

Financial Health

Revenue Growth31.00%
Profit Margin3.26%
P/E Ratio50.0
ROE7.04%
ROA4.08%
Debt/Equity33.52
P/B Ratio3.3
Industry P/E29.5

Technical Analysis

TrendNeutral
RSI48.1
Support¥1,592.00
Resistance¥1,810.00
MA 20¥1,686.75
MA 50¥1,745.98
MA 200¥1,615.74
MACDBullish
VolumeIncreasing
Fear & Greed Index89.95

Valuation

GradeOvervalued
TypeGrowth

Risk Assessment

Beta0.36
Volatility29.90%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.